Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C.

Source:http://linkedlifedata.com/resource/pubmed/id/11528252

Download in:

View as

General Info

PMID
11528252